Gene · 5350
Papers4,369
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,369
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study. | Circulation | 2022 | 36205131 | PubTator, text mining | PubMed |
| Bioinformatics analysis of inflammation and oncology in pulmonary lymphangioleiomyomatosis. | Medicine (Baltimore) | 2022 | 36197266 | PubTator, text mining | PubMed |
| Ontogeny of cardiomyocytes: ultrastructure optimization to meet the demand for tight communication in excitation-contraction coupling and energy transfer. | Philos Trans R Soc Lond B Biol Sci | 2022 | 36189816 | PubTator, text mining | PubMed |
| Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation. | World J Clin Cases | 2022 | 36186184 | PubTator, text mining | PubMed |
| Genetic Evaluation of A Nation-Wide Dutch Pediatric DCM Cohort: The Use of Genetic Testing in Risk Stratification. | Circ Genom Precis Med | 2022 | 36178741 | PubTator, text mining | PubMed |
| Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta. | Arterioscler Thromb Vasc Biol | 2022 | 36172868 | PubTator, text mining | PubMed |
| Anti-malarial drugs: Mechanisms underlying their proarrhythmic effects. | Br J Pharmacol | 2022 | 36165125 | PubTator, text mining | PubMed |
| Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics. | Front Cardiovasc Med | 2022 | 36158814 | PubTator, text mining | PubMed |
| Mobile Anchors. | Function (Oxf) | 2022 | 36156892 | PubTator, text mining | PubMed |
| Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy. | Ann Nucl Med | 2022 | 36155888 | PubTator, text mining | PubMed |
| Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy. | Circulation | 2022 | 36154167 | PubTator, text mining | PubMed |
| Exercise-induced arrhythmogenic right ventricular cardiomyopathy: Reverse remodeling with detraining. | HeartRhythm Case Rep | 2022 | 36147714 | PubTator, text mining | PubMed |
| Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives. | Pharmaceutics | 2022 | 36145711 | PubTator, text mining | PubMed |
| Cell-Based and Selected Cell-Free Therapies for Myocardial Infarction: How Do They Compare to the Current Treatment Options? | Int J Mol Sci | 2022 | 36142245 | PubTator, text mining | PubMed |
| Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options. | Biomedicines | 2022 | 36140374 | PubTator, text mining | PubMed |
| NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction. | Antioxidants (Basel) | 2022 | 36139898 | PubTator, text mining | PubMed |
| Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease. | Biomolecules | 2022 | 36139162 | PubTator, text mining | PubMed |
| Applications of Molecular Dynamics Simulation in Protein Study. | Membranes (Basel) | 2022 | 36135863 | PubTator, text mining | PubMed |
| MiR-942-3p as a Potential Prognostic Marker of Gastric Cancer Associated with AR and MAPK/ERK Signaling Pathway. | Curr Issues Mol Biol | 2022 | 36135175 | PubTator, text mining | PubMed |
| CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration. | BMC Urol | 2022 | 36131343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5350/papers?page=37